Diaprost
Company

General

About Company
Diaprost is developing an antibody platform for the detection and diagnosis of prostate cancer.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2005

Company Type

For Profit

IPO status

Private

Description

Diaprost, headquartered in Lund, is a biotech company specializing in research and development for prostate cancer. Their main goal is to create an antibody platform that can be used for in vitro diagnostics and the identification of prostate cancer. Additionally, Diaprost offers diagnostic and therapeutic services to treat prostate cancer.
Contacts

location

Phone number